GLP-1 weight management, prescribed personally.*
Semaglutide is a long-acting GLP-1 receptor agonist. Tides prescribes a compounded formulation with full labs, clinician-managed titration, and quarterly review. Compounded semaglutide is not FDA-approved and is not the same product as brand-name GLP-1s.
Quick read
Read the full science
What it does
Appetite reduction that holds
GLP-1 receptor activation in the brain dampens hunger signals and reduces food noise. Once-weekly dosing carries the effect cleanly through the full week.Improved insulin response
GLP-1 action on pancreatic beta cells improves how cleanly the body handles glucose at meals. A1C and fasting insulin both shift in measurable timeframes.Steady, controlled weight loss
Reduced calorie intake plus slower gastric emptying drives gradual, sustainable weight reduction. Paired with full labs and quarterly review so the protocol stays calibrated to you.Metabolic markers move with you
Lipids, blood pressure, and inflammatory markers tend to move in the right direction alongside weight loss. The body composition shift is a downstream effect of the metabolic reset.
How it works
Semaglutide is a long-acting GLP-1 receptor agonist. It binds the GLP-1 receptor in the brain (appetite center), the gut (slows stomach emptying so meals feel filling longer), and the pancreas (improves glucose-responsive insulin release). Tides prescribes a compounded formulation through a US 503A pharmacy, with full lab panels and clinician-managed dose titration. Compounded semaglutide is not FDA-approved and is not the same product as brand-name GLP-1s.
Clinical context
- Typical dose
- 2.4 mg weekly
- Range
- 0.25–2.4 mg/week
- Route
- Subcutaneous
- Per vial
- 25 mg · ~73 days
- Required labs
- A1C, Lipid Panel, Comprehensive Metabolic Panel, Lipase
Who it's for
- Meaningful, supervised weight loss
- Prediabetic A1C or insulin resistance markers
- Patients who want quarterly clinician review, not a one-time prescription
- Body composition reset alongside training
Cautions
- Mandatory titration: every patient starts at 1 mg/week
- Quarterly clinical review required (every 90 days)
- Not for personal or family history of medullary thyroid carcinoma
Pairs with
Semaglutide compounded vial. Cycle length depends on your prescribed dose, Rachel calibrates the titration to you. Pharmacy and clinician fees included.
Priced by dose
As Dr. Rachel advances your protocol, price and shipment step up together. Every step is priced separately so you always know what the next one costs before it happens.
Your dose and price step up together as Dr. Rachel advances your protocol. She will discuss any change with you first.
- Unit size
- 25 mg vial
- Prescribed dose
- 2.4 mg weekly
- Frequency
- weekly
- How long one unit lasts
- about 10 weeks per vial
- vials per year
- 4 vials over 12 months
- Per month
- $179
- Per dose
- about $41
- Clinician review by Dr. Rachel Deutsch, DNPShe reviews your case and prescribes the protocol. Every 4th refill returns to her for a scheduled check-in, and she can adjust that cadence based on your specific care. Not a bot, not a checkbox.
- Compounding by a licensed US pharmacy503A partnership. Every batch traceable, every ingredient sourced under FDA oversight.
- Temperature-controlled shipping when requiredTemperature-controlled packaging for injectables that need it. Ground shipping for orals and topicals.
- Unlimited messaging with your care teamAsk Rachel anything, any time. Dr. Rachel typically replies within one business day.
- No charge until Rachel approves your orderYour card is authorized at checkout, captured only when Rachel signs off. If she declines, nothing is charged.